W
Wenping Li
Researcher at Georgetown University Medical Center
Publications - 14
Citations - 858
Wenping Li is an academic researcher from Georgetown University Medical Center. The author has contributed to research in topics: Cell growth & Cancer. The author has an hindex of 10, co-authored 12 publications receiving 812 citations.
Papers
More filters
Journal ArticleDOI
Peripheral-type benzodiazepine receptor-mediated action of steroidogenic acute regulatory protein on cholesterol entry into Leydig cell mitochondria
Thierry Hauet,Zhi-Xing Yao,Himangshu S. Bose,Christopher T. Wall,Zeqiu Han,Wenping Li,Dale B. Hales,Walter L. Miller,Martine Culty,Vassilios Papadopoulos +9 more
TL;DR: Reincorporation of in vitro transcribed/translated PBR, but not PBR missing the cholesterol-binding domain, into MA-10 mitochondria rescued the ability of the mitochondria to form steroids and the ability to respond to StAR and Tom/StAR proteins.
Journal ArticleDOI
In Utero Exposure to Di-(2-ethylhexyl) Phthalate Exerts Both Short-Term and Long-Lasting Suppressive Effects on Testosterone Production in the Rat
Martine Culty,Raphael Thuillier,Wenping Li,Yan Wang,Daniel B. Martinez-Arguelles,Daniel B. Martinez-Arguelles,Carolina Gesteira Benjamin,Konstantinos M. Triantafilou,Barry R. Zirkin,Vassilios Papadopoulos,Vassilios Papadopoulos +10 more
TL;DR: Results demonstrate that in utero DEHP exposure exerts both short-term and long-lasting effects on testicular steroidogenesis that might involve distinct molecular targets in fetal and adult Leydig cells.
Journal ArticleDOI
Expression of Peripheral Benzodiazepine Receptor (PBR) in Human Tumors: Relationship to Breast, Colorectal, and Prostate Tumor Progression
TL;DR: It is proposed that PBR overexpression could serve as a novel prognostic indicator of an aggressive phenotype in breast, colorectal and prostate cancers, where elevated PBR expression is associated with tumor progression.
Journal ArticleDOI
Peripheral-type benzodiazepine receptor (PBR) and PBR drug ligands in fibroblast and fibrosarcoma cell proliferation: role of ERK, c-Jun and ligand-activated PBR-independent pathways.
TL;DR: It is suggested that in fibroblasts and fibrosarcoma cells PBR drug ligands inhibit cell proliferation in a PBR-independent manner, and this results are in contrast to data reported on cells of epithelial origin, suggesting that the origin of the cells is crucial in defining the role of PBR in their proliferation.
Journal ArticleDOI
Molecular Mechanisms Mediating the Effect of Mono-(2-Ethylhexyl) Phthalate on Hormone-Stimulated Steroidogenesis in MA-10 Mouse Tumor Leydig Cells
Jinjiang Fan,Kassim Traore,Kassim Traore,Wenping Li,Hakima Amri,Hongzhan Huang,Cathy H. Wu,Haolin Chen,Barry R. Zirkin,Vassilios Papadopoulos +9 more
TL;DR: The molecular and cellular mechanisms underlying the effects of MEHP on basal and human chorionic gonadotropin (hCG)-stimulated steroid production by MA-10 Leydig cells are addressed using a systems biology approach.